Innovating Targeted Cancer Therapies
HUTCHMED (hutch-med.com) scores 63 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 9th percentile of 13252 Healthcare brands.
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is a commercial-stage, innovative biopharmaceutical company headquartered in Hong Kong. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, serving patients, healthcare providers, researchers, and investors worldwide.
| Brand Name | HUTCHMED |
|---|---|
| Domain | hutch-med.com |
| Industry | Healthcare |
| Headquarters | Hong Kong |
| Main Competitors | Hengrui Pharmaceuticals (62/100), BeiGene (85/100), Zai Lab (77/100), Innovent Biologics (67/100), Junshi Biosciences (68/100), AstraZeneca (82/100), Eli Lilly (78/100), Bristol Myers Squibb (89/100) |
Moz Domain Authority 27/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "HUTCHMED (Nasdaq/AIM:HCM;HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of ta…" (Meta description: 33 words. No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, YouTube; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is HUTCHMED?", Claude could identify the brand as of October 2026. HUTCHMED is a biopharmaceutical company focused on discovering, developing and commercializing targeted therapies and immunotherapies for cancer and immunological diseases, with significant operations in China and global reach. It's known for drugs like fruquintinib (Fruzaqla) an Best known for Developing fruquintinib (Fruzaqla), an oncology drug for colorectal cancer, and its deep roots in China's biopharma sector.
When asked "Best brands similar to HUTCHMED?", Claude would recommend HUTCHMED as of October 2026. It's a legitimate and increasingly prominent oncology-focused biopharma company, so I'd mention it when discussing China-based or global cancer drug developers.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
HUTCHMED's main competitors in Healthcare: Hengrui Pharmaceuticals (62/100), BeiGene (85/100), Zai Lab (77/100), Innovent Biologics (67/100), Junshi Biosciences (68/100).
Sources: Brand Analyzer scan
HUTCHMED is a commercial-stage, innovative biopharmaceutical company listed on Nasdaq/AIM under the ticker HCM and on the Hong Kong Stock Exchange under 13. It is headquartered in Hong Kong and focuses on the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases.
Sources: HUTCHMED official site
HUTCHMED has low AI-search visibility, scoring 23/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 22, recommendation 27). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: HUTCHMED official site
HUTCHMED is headquartered in Hong Kong. HUTCHMED operates in the Healthcare category.
Sources: Wikidata
HUTCHMED discovers, develops, and commercializes targeted therapies and immunotherapies aimed at treating cancer and immunological diseases. Its work spans the full value chain from scientific discovery through global clinical development to bringing approved treatments to market for patients worldwide.
Sources: HUTCHMED official site
HUTCHMED scores 27/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: HUTCHMED official site
HUTCHMED can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: HUTCHMED official site
HUTCHMED is known for being a commercial-stage biopharmaceutical company specializing in targeted therapies and immunotherapies for cancer and immunological diseases, with a presence on major stock exchanges including Nasdaq, AIM, and the Hong Kong Stock Exchange.
Sources: HUTCHMED official site
HUTCHMED's offerings are intended for patients with cancer and immunological diseases, and the company engages with healthcare providers and medical researchers in the development and application of its therapies. Additionally, investors interested in innovative biopharmaceutical companies follow HUTCHMED due to its public listings.
Sources: HUTCHMED official site
HUTCHMED scores 23/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
HUTCHMED has a weak AI-visibility profile at 23/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (27/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 27/100 and thin schema.org structured data. In a live check, Claude could already identify HUTCHMED from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to HUTCHMED: Hjärnkraft (63/100), HeartCloud (63/100), iCentrix Analytics (63/100), İnnovamed (63/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.